- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04690218
Evaluation of Sleep Quality, Nutrition, Anxiety and Depression in Mastalgia
January 1, 2022 updated by: Alirıza Erdoğan, Nigde Omer Halisdemir University
The aim of this study is to investigate the sleep quality, anxiety and depression levels in women with mastalgia using internationally validated scales.
Additionally the investigators aim to question the amount and frequency of consumption of nutritional elements which are known to aggravate mastalgia.
Finally by combining and analyzing the information gathered, the investigators intend to set light to the etiopathologic and clinic aspects of mastalgia.
Study Overview
Status
Completed
Conditions
Detailed Description
Mastalgia is encountered in 70% of premenopausal women and is one of the most frequent reasons for attending general surgery clinics.
In most of the cases no physical cause is demonstrated and the etiopathogenesis is still not yet determined.
In 1949 Patey, for the first time, proposed that mastalgia might be a psychologically based problem.
In the following years, research was focused in this issue and some articles were published demonstrating the relationship of anxiety, depression and high stress levels with mastalgia.
The efforts for finding out the etiopathologic mechanism and defining the risk factors revealed that smoking and consumption of tea, coffee and carbonated beverages in particular worsen mastalgia whereas essential fatty acids (especially gamma linoleic acid) provides a symptomatic relief.
Additionally it is known that sleep irregularities cause serious deterioration in daily life quality as well as can exaggerate some medical, neurologic and/or psychiatric conditions.
More than half of the population experience sleep irregularities from time to time and chronic sleep disturbances effect 20% of adult population in western countries.
Therefore sleep irregularities might have contributing effects in the etiopathogenesis and/or symptomatology of therapy resistant conditions like mastalgia.
Study Type
Observational
Enrollment (Actual)
217
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Niğde, Turkey, 51100
- Niğde Ömer Halisdemir University Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
This case-controlled study will consist of 2 groups; Mastalgia group (women with confirmed mastalgia) and controls (women without mastalgia).
Description
Inclusion Criteria:
- Having mastalgia as a presenting symptom (mastalgia group)
- Presence of mastalgia confirmed by a general surgeon (mastalgia group)
- Absence of mastalgia (control group)
Exclusion Criteria:
- Previously diagnosed breast carcinoma (both groups)
- Previously exposed to thoracic radiotherapy (both groups)
- Previous breast or thoracic surgery for any reason (both groups)
- Presence of Tietze syndrome (both groups)
- Use of nutritional supplements (both groups)
- Presence of any self-perceived pain (control group)
- Presence of psychogenic based conditions and psychosomatic illnesses (control group)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Mastalgia
"Mastalgia" group will consist of women with confirmed mastalgia.
The patients will be asked to fulfill the forms of Hospital Anxiety and Depression Scale and Pittsburgh Sleep Quality Index.
Additionally patients will be asked to inform the frequency and amount of consumption of certain nutritional elements by a questionnaire.
|
Self assessment scale suitable for hospital community as well as public community.
Applying the scale does not require any psychopathologic training.
Self assessment scale for public community.
Applying the scale does not require any specially trained personnel.
It consists of 26 items, questioning the frequency and amount of certain nutritional elements (ones known to worsen and benefit mastalgia) consumed by the individual.
|
Controls
"Controls" group will consist of women attending to general surgery clinic for reasons other than mastalgia.
The patients will be asked to fulfill the forms of Hospital Anxiety and Depression Scale and Pittsburgh Sleep Quality Index.
Additionally patients will be asked to inform the frequency and amount of consumption of certain nutritional elements by a questionnaire.
|
Self assessment scale suitable for hospital community as well as public community.
Applying the scale does not require any psychopathologic training.
Self assessment scale for public community.
Applying the scale does not require any specially trained personnel.
It consists of 26 items, questioning the frequency and amount of certain nutritional elements (ones known to worsen and benefit mastalgia) consumed by the individual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Anxiety and Depression Score
Time Frame: 9 months
|
Hospital Anxiety and Depression Score is four point likert type scale.
It consists of 14 questions.
Questions 1, 3, 5, 7, 9, 11 and 13 address anxiety whereas questions 2, 4, 6, 8, 10, 12 and 14 address depression.
Achievable minimum score of the scale is 0 and the maximum score is 42.
The cut-off score for depression is 7 and for anxiety is 10.
Scores higher than 7 indicate high anxiety levels and scores higher than 10 indicate the presence of depression.
|
9 months
|
Pittsburgh Sleep Quality Index
Time Frame: 9 months
|
Pittsburgh Sleep Quality Index consists of 7 component.
The possible scoring range of the scale is 0-21.
The high scores indicates bad sleep quality.
The cutt-off value is 5.
|
9 months
|
The amount of nutritional elements consumed which worsen mastalgia
Time Frame: 9 months
|
Calculated as the number stated by the individual (times consumed per day/week/month)
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The amount of other nutritional elements consumed
Time Frame: 9 months
|
Calculated as the number stated by the individual (times consumed per day/week/month)
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
- Kanat BH, Atmaca M, Girgin M, Ilhan YS, Bozdag A, Ozkan Z, Yazar FM, Emir S. Effects of Mastalgia in Young Women on Quality of Life, Depression, and Anxiety Levels. Indian J Surg. 2016 Apr;78(2):96-9. doi: 10.1007/s12262-015-1325-5. Epub 2015 Aug 28.
- PATEY DH. Two common non-malignant conditions of the breast; the clinical features of cystic disease and the pain syndrome. Br Med J. 1949 Jan 15;1(4593):96-9. doi: 10.1136/bmj.1.4593.96. No abstract available.
- Preece PE, Mansel RE, Hughes LE. Mastalgia: psychoneurosis or organic disease? Br Med J. 1978 Jan 7;1(6104):29-30. doi: 10.1136/bmj.1.6104.29.
- Johnson KM, Bradley KA, Bush K, Gardella C, Dobie DJ, Laya MB. Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes. J Gen Intern Med. 2006 Mar;21 Suppl 3(Suppl 3):S70-5. doi: 10.1111/j.1525-1497.2006.00378.x.
- Colegrave S, Holcombe C, Salmon P. Psychological characteristics of women presenting with breast pain. J Psychosom Res. 2001 Jun;50(6):303-7. doi: 10.1016/s0022-3999(01)00196-9.
- Ader DN, South-Paul J, Adera T, Deuster PA. Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol. 2001 Jun;22(2):71-6. doi: 10.3109/01674820109049956.
- Idiz C, Cakir C, Ulusoy AI, Idiz UO. The Role of Nutrition in Women with Benign Cyclic Mastalgia: A Case-Control Study. Eur J Breast Health. 2018 Jul 1;14(3):156-159. doi: 10.5152/ejbh.2018.3827. eCollection 2018 Jul.
- Soldatos CR, Paparrigopoulos TJ. Sleep physiology and pathology: pertinence to psychiatry. Int Rev Psychiatry. 2005 Aug;17(4):213-28. doi: 10.1080/09540260500104565.
- Barthlen GM, Stacy C. Dyssomnias, parasomnias, and sleep disorders associated with medical and psychiatric diseases. Mt Sinai J Med. 1994 Mar;61(2):139-59.
- Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Med Rev. 2016 Feb;25:52-73. doi: 10.1016/j.smrv.2015.01.009. Epub 2015 Feb 17.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2021
Primary Completion (ACTUAL)
December 31, 2021
Study Completion (ACTUAL)
December 31, 2021
Study Registration Dates
First Submitted
December 26, 2020
First Submitted That Met QC Criteria
December 26, 2020
First Posted (ACTUAL)
December 30, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 4, 2022
Last Update Submitted That Met QC Criteria
January 1, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020/86
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mastodynia
-
Bionorica SECompletedPremenstrual Syndrome | Cyclic MastodyniaCzech Republic
-
University of PortsmouthPortsmouth Hospitals NHS TrustCompleted
-
Pinggu Hospital of Beijing Traditional Chinese...Pinggu huangsongyu Community hospital; Pinggu Xiagezhuang Community hospitalRecruiting
-
New York Institute of TechnologyWithdrawn
-
Sisli Hamidiye Etfal Training and Research HospitalCompleted
-
Guang'anmen Hospital of China Academy of Chinese...Recruiting
-
University of ConnecticutNational Institute of Nursing Research (NINR)CompletedBreastfeeding | Breast PainUnited States
-
Wake Forest University Health SciencesCompleted
-
Mountain States Tumor and Medical Research InstituteCompleted
Clinical Trials on Hospital anxiety and depression scale
-
Henan Cancer HospitalRecruitingDepression | Anxiety | Malignant TumorChina
-
Sultan Abdulhamid Han Training and Research Hospital...CompletedDepression | Cancer | Covid19 | Anxiety | Chronic DiseaseTurkey
-
Institut de Cancérologie de la LoireCompleted
-
Université Catholique de LouvainActive, not recruiting
-
University of NottinghamNot yet recruitingColorectal (Colon or Rectal) CancerUnited Kingdom
-
NYU Langone HealthCompleted
-
University of ZurichUnknownPsychological Distress | Relatives | PolytraumaSwitzerland
-
Ain Shams Maternity HospitalUnknown